Takeda

Pharmas form joint venture to jumpstart Japanese drug research
BioPharma Dive
Mon, 04/22/24 - 11:29 am
Japan
R&D
Takeda
Astellas
Sumitomo Mitsui Banking
Takeda inks sweet $1.2B+ deal with Kumquat for immuno-oncology program
Fierce Biotech
Tue, 04/16/24 - 10:10 pm
Takeda
Kumquat Biosciences
biobucks
immuno-oncology
Top five biopharma companies hiring in San Diego
BioSpace
Thu, 04/11/24 - 10:55 am
San Diego
biotech
hirings
Avidity Biosciences
Element Biosciences
AnaptysBio
Fate Therapeutics
Takeda
Takeda plots ‘unprecedented patient diversity’ for psoriasis drug that could compete with BMS
Pharma Voice
Wed, 03/27/24 - 10:56 am
Takeda
cliincal trials
TAK-279
Bristol Myers Squibb
clinical trial diversity
psoriasis
Big Pharma CEOs gather in Beijing to ⁠show continued interest in China, offer policy advice
Fierce Pharma
Tue, 03/26/24 - 04:26 pm
China
Pharma CEOs
AstraZeneca
Bayer
Bristol Myers Squibb
GSK
Novartis
Pfizer
Takeda
FDA Approves Iclusig for New Patients with Aggressive Leukemia
Managed Healthcare Executive
Tue, 03/19/24 - 09:20 pm
Takeda
Iclusig
FDA
acute lymphoblastic leukemia
Takeda’s Eohilia to compete Sanofi’s Dupixent in eosinophilic esophagitis treatment
Clinical Trials Arena
Thu, 02/29/24 - 11:11 am
Takeda
Eohilia
Sanofi
Dupixent
EoE
eosinophilic esophagitis
FDA approves Takeda's therapy for allergic inflammation in esophagus
Reuters
Mon, 02/12/24 - 10:21 am
Takeda
FDA
Eohilia
eosinophilic esophagitis
Takeda Pushes One Narcolepsy Program into Phase III, Discontinues Another
BioSpace
Fri, 02/9/24 - 11:18 am
Takeda
clinical trials
TAK-861
narcolepsy
Sanofi, Takeda announce CFO changes as part of earnings releases
Medical Marketing and Media
Fri, 02/2/24 - 11:48 am
Sanofi
Takeda
CFOs
earnings
Despite Vyvanse's loss of exclusivity, Takeda treads water thanks to launch momentum
Fierce Pharma
Fri, 02/2/24 - 11:43 am
Takeda
ADHD
Vyvanse
earnings
Takeda grabs late-stage hematology drug from Protagonist
Pharmaphorum
Thu, 02/1/24 - 11:20 am
Takeda
hematology
Protagonist Therapeutics
polycythemia vera
Five years after Shire deal, Takeda looks to reap rewards of latest reinvention
BioPharma Dive
Fri, 01/19/24 - 11:12 am
Takeda
M&A
Shire
fruquintinib
Exkivity
Top 5 Life Science Companies Hiring Remote
BioSpace
Thu, 01/18/24 - 11:12 am
remote work
hirings
Takeda
AbbVie
Moderna Therapeutics
Biomarin
CSL Behring
Takeda Gets FDA Label Expansion for HyQvia in Rare Autoimmune Disorder
BioSpace
Wed, 01/17/24 - 08:27 pm
Takeda
FDA
HyQvia
demyelinating polyneuropathy
JPM 24: How Takeda beat 'almost every biopharmaceutical company' to win Nimbus’ TYK2 med
Fierce Biotech
Thu, 01/11/24 - 11:17 am
Takeda
TAK-279
Nimbus Therapeutics
JPMHC 2024
Drugmakers set to raise US prices on at least 500 drugs in January
Reuters
Tue, 01/2/24 - 09:59 am
drug pricing
Pfizer
Sanofi
Takeda
Takeda’s gene therapy pivot leaves JCR behind after proof-of-concept preclinical test
Fierce Biotech
Thu, 12/21/23 - 09:57 am
Takeda
gene therapy
JCR Pharma
Takeda’s Fruzaqla (Fruquintinib) Gets FDA Nod for Metastatic Colorectal Cancer
Xtalks
Thu, 12/21/23 - 09:42 am
Takeda
FDA
colorectal cancer
fruquintinib
Fruzaqla
Takeda snares approval for all-comer gastric cancer drug
Medical Marketing and Media
Sun, 11/12/23 - 09:23 pm
Takeda
Fruzaqla
colorectal cancer

Pages